Switzerland· 51950005
Berinert IV
A c1-inhibitor, plasma derived product containing proteina plasmatis humani, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
C1-inhibitor, plasma derived is registered in 11 of 19 countries.
Countries holding a registration under ATC B06AC01 (c1-inhibitor, plasma derived), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
C1-inhibitor, plasma derived · ATC B06AC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- proteina plasmatis humani
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- B06AC01
- ATC class
- C1-inhibitor, plasma derived
- Defined daily dose
- 1.4 TSD, E
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680519500050Set 1 StkCHF 672.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
47 interactions on record for c1-inhibitor, plasma derived.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
C1-inhibitor, plasma derived · interactions on record
47 records
- 5 severe
- 42 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- ThalidomideL04AX02severe
- LenalidomideL04AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
C1-inhibitor, plasma derived in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainOCTAPLASMALG (0) 45-70 MG/ML POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONOctapharma S.A.
- CzechiaCYMVIGOBiotest Pharma GmbH, Dreieich
- United KingdomOctaplas 11.5g/200ml infusion bagsOctapharma Ltd
- GermanyAlbumeonCsl Behring Gmbh
- BelgiumIntratect 50 g/lBiotest Pharma
- IrelandFlexbumin 200 g/l solution for infusionBaxalta Innovations GmbH
- United StatesOctaplasOctapharma USA Inc
- NorwayAlburexCSL Behring GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Albunorm, Alburex
- Belgium · Alburex, Human Albumin Csl Behring
- Bulgaria · Албурекс, Октапласlg
- Cyprus · Albumeon, Alburex
- Czechia · Alburex, Human Albumin Csl Behring
- Germany · Albumeon, Albunorm
- Denmark · Albumin Behring, Albunorm
- Estonia · Human Albumin Csl Behring, Octaplaslg
- Spain · Albúmina Humana Csl Behring, Albunorm
- Finland · Albumin Behring, Albunorm
- France · Albumine Humaine Csl Behring, Albunorm
- United Kingdom (Northern Ireland) · Albumeon, Alburex
- Greece · Albumeon, Alburex
- Croatia · Albumeon, Albunorm
- Hungary · Alburex, Human Albumin Csl Behring
- Ireland · Alburex, Human Albumin Csl Behring
- Iceland · Albumin Behring, Albunorm
- Italy · Albumeon, Albunorm
- Lithuania · Human Albumin Csl Behring, Octaplasma
- Luxembourg · Alburex, Human Albumin Csl Behring
- Latvia · Human Albumin Csl Behring, Octaplasma
- Malta · Albumeon, Alburex
- Netherlands · Albunorm, Alburex
- Norway · Albumin Behring, Albunorm
- Poland · Alburex, Human Albumin Csl Behring
- Portugal · Albumina Humana Csl Behring, Alburex
- Romania · Albumeon, Alburex
- Sweden · Albumin Behring, Albunorm
- Slovenia · Alburex, Humani Albumin Csl Behring
- Slovakia · Alburex, Human Albumin Csl Behring
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/89203460-9aae-4277-b5b2-00df1ca0c43b GET /v1/drugs/89203460-9aae-4277-b5b2-00df1ca0c43b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "c1-esterasi inhibitor humanus 500 UI",
"valid_from": "2025-03-01",
"limitations": "[{\"description\":\"Erbliches Angioödem<br>\\n- Therapie des akuten Schubes<br>\\n- Prophylaxe vor Operationen<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-03-01\",\"validTo\":null}]",
"galenic_form": "Trockensub 500 IE c Solv",
"therapeutic_area": null,
"sl_inclusion_date": "1997-03-15",
"self_retention_pct": 10
}See everything about c1-inhibitor, plasma derived.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.